In an IL-4-dependent manner Stat6 has been suggested to promote colorectal cancer due to its ability to polarize myeloid cells in a wound–healing/tumor-promoting alternative phenotype, which differentiates these cells from the tumor-suppressing IFNγ-mediated classical activation phenotype [18]. Here, STAT6 is linked to neoplasm.